Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-01-12Clinical Trial Update: Orodispersible Minitablets of Enalapril in Young Children With Heart Failure Due to Congenital Heart Disease [Phase 2, Phase 3]
Clinical trial update for a Phase 2/3 study of orodispersible minitablets of enalapril in young children with heart failure due to congenita…
-
CLINICAL_TRIALS trial_result · 2016-01-11Clinical Trial Update: Exploring Behavioral Interventions to Improve Heart Failure [NA]
The document reports the completion of a UC San Diego clinical trial evaluating behavioral interventions to improve outcomes in heart failur…
-
FDA approval · 2016-01-11FDA Approved: VALSARTAN — Original Application (Amneal Pharmaceuticals LLC)
FDA approves Amneal Pharmaceuticals LLC's Original Application for VALSARTAN, authorizing the marketing of a generic valsartan product.
-
FDA approval · 2016-01-10FDA Approved: DIGOXIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Digoxin from Hikma Pharmaceuticals USA Inc., indicating a supplemental approval (AP) for the pro…
-
CLINICAL_TRIALS research · 2016-01-08Clinical Trial Update: Evaluating Teach Back as a Method for Improving Self-Care Behaviours in Heart Failure Patients [NA]
A completed clinical trial evaluating Teach Back as a method to improve self-care behaviors in heart failure patients (sponsored by Unity He…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-01-08Clinical Trial Update: Predictors of Heart Failure After ST-segment Elevation Myocardial Infarction (HF-EXPRESS)
The HF-EXPRESS trial update investigates predictors of developing heart failure after a ST-elevation myocardial infarction, with the trial s…
-
CLINICAL_TRIALS research · 2016-01-08Clinical Trial Update: Effects of GLP-1 on Chronic Heart Failure [NA]
This entry reports an ongoing clinical trial evaluating the effects of GLP-1 on chronic heart failure; the trial status is currently unknown…
-
CLINICAL_TRIALS research · 2016-01-07Clinical Trial Update: Non-steroidal Anti-inflammatory Drugs (NSAIDs) and Risk of Acute Kidney Injury in Patients With Heart Failure
An update on a clinical trial examining whether non-steroidal anti-inflammatory drugs increase the risk of acute kidney injury in patients w…
-
CLINICAL_TRIALS research · 2016-01-07Clinical Trial Update: Clinical and Morphological Characteristics of Chronic Inflammation in the Myocardium in Patients With Decompensated HF With Ischemic Systolic Dysfunction [NA]
Clinical trial update describing chronic inflammation characteristics in the myocardium in patients with decompensated heart failure due to …
-
FDA label_change · 2016-01-06FDA Approved: FARXIGA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Farxiga (dapagliflozin), resulting in changes to the product labeling.
-
CLINICAL_TRIALS trial_result · 2016-01-06Clinical Trial Update: PACMAN - PAcing for CardioMyopathies, a EuropeAN Study [Phase 4]
Phase 4 clinical trial update for PACMAN evaluating pacing therapy for cardiomyopathy in heart failure; the study sponsored by Boston Scient…
-
CLINICAL_TRIALS trial_result · 2016-01-06Clinical Trial Update: Does Detailed Informed Consent for Cardiopulmonary Resuscitation and Mechanical Ventilation Impact Patients' Decisions and Outcomes? [NA]
This clinical trial update examines whether providing detailed informed consent for CPR and mechanical ventilation affects patients' decisio…
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: Safety, Tolerability, Pharmacokinetic, Including Food Interaction, and Pharmacodynamic Profile of BIA 5-1058. [Phase 1]
Phase 1 trial evaluating safety, tolerability, pharmacokinetics, including food interactions, and pharmacodynamics of BIA 5-1058 in hyperten…
-
FDA approval · 2016-01-04FDA Approved: LISINOPRIL — Supplemental Application (Solco healthcare U.S., LLC)
FDA approved a supplemental application for lisinopril from Solco Healthcare U.S., LLC, supporting continued availability of the generic ACE…
-
CLINICAL_TRIALS trial_result · 2015-12-30Clinical Trial Update: Necklace-Shaped Sensor for Non-Invasive Remote Monitoring of Vitals
A Baxter-sponsored clinical trial assessing a necklace-shaped sensor for non-invasive remote monitoring of vitals in heart failure and hyper…
-
CLINICAL_TRIALS trial_result · 2015-12-30Clinical Trial Update: Teledi@Log - Tele-rehabilitation of Heart Patients [NA]
A completed clinical trial update for the Teledi@Log tele-rehabilitation program for heart patients, including conditions such as heart fail…
-
CLINICAL_TRIALS trial_result · 2015-12-30Clinical Trial Update: Salt Sensitivity, Cardiovascular and Metabolic Disease
A completed clinical trial investigating salt sensitivity in cardiovascular and metabolic diseases.
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) [Phase 3]
Phase 3 REMATCH trial evaluating left ventricular assist devices versus medical therapy for end-stage heart failure. The study status is com…
-
CLINICAL_TRIALS research · 2015-12-22Clinical Trial Update: Graz Study on the Risk of Atrial Fibrillation [Phase 4]
Phase 4 clinical trial update from the Medical University of Graz examining the risk of atrial fibrillation in patients with hypertension an…
-
CLINICAL_TRIALS research · 2015-12-18Clinical Trial Update: Goal Directed Hemodynamic Management of Acute Heart Failure After Cardiac Surgery in Children [Phase 3]
Phase 3 clinical trial evaluating goal-directed hemodynamic management for acute heart failure in children after cardiac surgery.
-
FDA approval · 2015-12-17FDA Approved: VALSARTAN — Supplemental Application (Ohm Laboratories Inc.)
FDA approved a supplemental application for VALSARTAN from Ohm Laboratories Inc. (ANDA077492).
-
FDA approval · 2015-12-16FDA Approved: METOPROLOL SUCCINATE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for metoprolol succinate by Quallent Pharmaceuticals Health LLC, indicating approval of the suppleme…
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: Palliative Care for Patients With Advanced Heart Disease [Phase 2]
Phase 2 clinical trial evaluating palliative care for patients with advanced heart disease has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: Evaluation of Patiromer in Heart Failure Patients [Phase 2]
Phase 2 trial evaluating patiromer in patients with hyperkalemia and heart failure has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: INcrease Of VAgal TonE in CHF [Phase 3]
A Phase 3 trial evaluating increasing vagal tone in heart failure has been terminated.